Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020505 (
hyperphagia
)
6,116
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The authors compared eating patterns, disordered eating, features of eating disorders, and depressive symptoms in persons with binge eating disorder (BED; n = 177), with night eating syndrome (
NES
; n = 68), and in an overweight comparison group without BED or
NES
(comparison; n = 45). Participants completed semistructured interviews and several established measures. Depressive symptoms were greater in the BED and
NES
groups than in the comparison group.
NES
participants ate fewer meals during the day and more during the night than BED and comparison participants, whereas BED participants ate more during the day than the comparison participants. BED participants reported more objective bulimic and
overeating
episodes, shape/weight concerns, disinhibition, and hunger than
NES
and comparison participants, whereas
NES
participants reported more eating pathology than comparison participants. This evaluation provides strong evidence for the distinctiveness of the BED and
NES
constructs and highlights their clinical significance.
...
PMID:Binge eating disorder and night eating syndrome: a comparative study of disordered eating. 1639 84
The treatment of night eating syndrome, a disorder characterized by evening
hyperphagia
, morning anorexia, and insomnia, continues to gain attention with its inclusion in the DSM-V. Known treatments for
NES
include pharmacological, phototherapy, weight loss and dietary, and psychological interventions, which, together with the syndrome's clinical characteristics, support a treatment guiding biobehavioral model. The biobehavioral model proposes that a genetic predisposition, coupled with stress, enhances midbrain serotonin transporter (SERT) binding, which results in lower post-synaptic serotonin, dysregulating circadian rhythms and decreasing satiety. Selective serotonin reuptake inhibitors should therefore decrease SERT binding, increase postsynaptic serotonin, and restore circadian function and satiety regulation. Psychological interventions may be used to decrease stress as well as address insomnia and circadian rhythm disruptions. Dietary and behavioral interventions may produce beneficial changes in satiety as well as dysregulated eating. Avenues for future treatment outcome studies, including alternative pharmacological and combination therapies, are discussed.
...
PMID:The Treatment of Night Eating Syndrome: A Review and Theoretical Model. 2662 76